{"id":"W4399543904","doi":"10.1007/s12325-024-02902-0","title":"De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel Fumarate","year":2024,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Biogen","keywords":"Medicine; Fingolimod; Multiple sclerosis; Ocrelizumab; Internal medicine; Expanded Disability Status Scale; Adverse effect; Clinical trial; Immunology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004187802,0.0002950416,0.0008421176,0.0004012625,0.0001247489,0.00007996573,0.0001286784,0.00006500931,0.00006700674],"category_scores_gemma":[0.0006539272,0.0002295511,0.0001175376,0.0006558608,0.00004978525,0.0004531285,0.00005070553,0.0001971022,0.00000682493],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002590772,"about_ca_system_score_gemma":0.0001659239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004639851,"about_ca_topic_score_gemma":0.002570591,"domain_scores_codex":[0.997844,0.0001165525,0.0005669597,0.0005895062,0.0004077973,0.0004751445],"domain_scores_gemma":[0.9973898,0.00177691,0.00008755615,0.0003835504,0.0001678404,0.0001943608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009467843,0.0004351784,0.8173056,0.0002469159,0.0002315564,0.00001067997,0.01525727,0.001945383,0.08985792,0.0001823808,0.00005538571,0.0650039],"study_design_scores_gemma":[0.005892437,0.0005347155,0.9780795,0.00132164,0.00001210305,6.381553e-7,0.0007890243,0.004705613,0.007131471,0.0003768846,0.000896105,0.0002598681],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805443,0.005391963,0.006354525,0.004180723,0.0001218743,0.003027995,0.0002603716,0.0000787033,0.00003956291],"genre_scores_gemma":[0.9771243,0.01266231,0.008015243,0.0006957832,0.00008619366,0.001249973,0.00006866831,0.0000637155,0.00003375427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1607739,"threshold_uncertainty_score":0.9360821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04441857967308863,"score_gpt":0.3346817676411522,"score_spread":0.2902631879680635,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}